Farms.com Home   News

New Automatic Milking Systems User Group for Wisconsin Dairy Producers

The University of Wisconsin-Madison Division of Extension created the Automatic Milking Systems (AMS) user group for dairy producers currently using AMS. The user group provides participants with opportunities to collaborate with peers, access expert guidance, contribute to research efforts, and improve farming practices, ultimately enhancing efficiency, productivity, and profitability on their dairy farms.

The group is facilitated by Douglas Reinemann from the University of Wisconsin Milking Research and Instruction Lab, and Carolina Pinzón, University of Wisconsin Extension Statewide Dairy Outreach specialist. 

The AMS User Group inaugural meeting is scheduled for Tuesday, April 9th, 2024, from 1 to 3:30 pm, offering both in-person (Wausau, WI) and virtual attendance options. Meetings will occur three times a year, with 10 to 20 AMS farms per meeting, held at various locations across Wisconsin, featuring optional AMS farm tours. 

Source : wisc.edu

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.